Concepedia

Publication | Open Access

Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women

DOIFull Paper Access

1.3K

Citations

44

References

2004

Year

Henry G. Bone, David Hosking, Jean‐Pierre Devogelaer, Joseph Tucci, Ronald Emkey, Richard P. Tonino, Jose Adolfo Rodriguez-Portales, Robert W. Downs, Jayanti Gupta, Arthur C. Santora,
New England Journal of Medicine

Abstract

The therapeutic effects of alendronate were sustained, and the drug was well tolerated over a 10-year period. The discontinuation of alendronate resulted in the gradual loss of its effects.

References

YearCitations

Page 1